InvestorsHub Logo
Followers 1
Posts 84
Boards Moderated 0
Alias Born 08/07/2019

Re: blue_skies post# 268

Wednesday, 10/07/2020 8:45:44 AM

Wednesday, October 07, 2020 8:45:44 AM

Post# of 459
I can't figure out what the issue is here other than maybe a plasma shortage could be negative for the stock.

I noticed GRFS was trending down at same time as KRMD but has had a nice little bounce recently - I thought their decline could have been plasma shortage related.

KRMD stock had a meteoric rise and was probably due for a breather. A 50% or so drop from the highs can be hard to take but the stock ran from < 1.50.

I see the market cap is about 6x their estimated 2022 revenues. Maybe the market perceives this as appropriate at this time.

One of the reasons I owned this was I thought their path to the 50 million in revs was more or less easily achievable. I also thought that they had, and do have, many hands in the fire with large pharma trials and the market was not pricing any of that in. I do think it only a matter of time before they have a positive "surprise" in that a new drug approval, or expanded indication for an existing drug will benefit them greatly.

No position at this time. I think the stock should have significant support in this $6-$7 range. All cash tied up (ATGN, VNTR, IPATF, CLPT). Still watching.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KRMD News